We’re excited to share that new UK guidelines for chimerism testing and monitoring after allogeneic stem cell transplant (HSCT) have just been published in the British Journal of Haematology: Click here
The guidelines bring together best practice recommendations from UK transplant, genomics and cancer genetics experts, including UK NEQAS for Leucocyte Immunophenotyping (UK NEQAS LI), to support consistent, high-quality chimerism testing for patients across the UK.
We’re particularly proud that UK NEQAS LI clinical scientist Dr Hazel Clouston is a co-author on this work, helping to ensure that the voice of external quality assessment and frontline laboratories is reflected throughout the recommendations.
Huge congratulations to Dr Andrew Clark and all the guideline authors on this important achievement.